|
| |
| | | 67280 | | 05.11.2020 | | Roche Pharma (Schweiz) AG | | | | | | | 20.07.2028 | | | | | | 07.16.10. | | | | 07.16.10. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Rozlytrek 100 mg | Hartkapseln | Capsules (Entrectinibum 100 mg) | L01EX14 | CI | | 02 | Rozlytrek 200 mg | Hartkapseln | Capsules (Entrectinibum 200 mg) | L01EX14 | CI |
|
|
|
